AXQ Capital LP Takes Position in Encompass Health Co. (NYSE:EHC)

AXQ Capital LP bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 10,671 shares of the company's stock, valued at approximately $985,000.

A number of other large investors have also modified their holdings of EHC. OneDigital Investment Advisors LLC acquired a new stake in Encompass Health in the 3rd quarter valued at about $207,000. CIBC Asset Management Inc lifted its position in Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company's stock worth $286,000 after buying an additional 100 shares in the last quarter. Natixis Advisors LLC boosted its stake in Encompass Health by 7.8% during the third quarter. Natixis Advisors LLC now owns 101,296 shares of the company's stock worth $9,789,000 after buying an additional 7,294 shares during the last quarter. Pathstone Holdings LLC grew its holdings in Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock valued at $2,032,000 after buying an additional 7,412 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in shares of Encompass Health by 14.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 44,017 shares of the company's stock worth $4,254,000 after acquiring an additional 5,647 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Down 0.5 %

Encompass Health stock traded down $0.54 during mid-day trading on Wednesday, reaching $100.33. 503,931 shares of the company's stock were exchanged, compared to its average volume of 633,615. Encompass Health Co. has a twelve month low of $77.09 and a twelve month high of $104.55. The company has a fifty day moving average of $98.42 and a 200-day moving average of $97.29. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company has a market cap of $10.10 billion, a P/E ratio of 22.50, a P/E/G ratio of 2.31 and a beta of 0.92.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. Encompass Health's payout ratio is currently 15.25%.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on EHC. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Barclays lifted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. KeyCorp raised their target price on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health has a consensus rating of "Buy" and a consensus target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.